{"DataElement":{"publicId":"4274277","version":"1","preferredName":"Malignant Neoplasm Gadolinium-Enhancing Non-Target Lesion RANO Criteria Assessment Follow-up Status","preferredDefinition":"The status related to the RANO response assessment (an update to the MacDonald criteria for assessing disease progression and treatment response in glioblastoma multiforme (GBM)) of T1 gadolinium enhancing non-target lesion sites.","longName":"RANOT1GADSTAT","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"4272260","version":"1","preferredName":"Malignant Neoplasm Gadolinium-Enhancing Non-Target Lesion RANO Criteria Assessment","preferredDefinition":"Information related to the RANO response assessment (an update to the MacDonald criteria for assessing disease progression and treatment response in glioblastoma multiforme (GBM)) of T1 gadolinium enhancing non-target lesion sites.  Gadolinium is a well-defined area of unequivocally increased signal intensity on MRI or CT scan images compared with the normal-appearing surrounding tissues, following intravenous injection of gadolinium-based contrast material.","longName":"RANOT1GAD","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"2186369","version":"1","preferredName":"Malignant Neoplasm","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-A888-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4274276","version":"1","preferredName":"Gadolinium-Enhancing Lesion Non-Target Response Assessment in Neuro-Oncology Criteria Assessment","preferredDefinition":"A well-defined area of unequivocally increased signal intensity on MRI or CT scan images compared with the normal-appearing surrounding tissues, following intravenous injection of gadolinium-based contrast material.:Other than the one for which something is done.:An update to the MacDonald criteria for assessing disease progression and treatment response in glioblastoma multiforme (GBM).:The final result of a determination of the value, significance, or extent of.","longName":"C28746:C25592:C114879:C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gadolinium-Enhancing Lesion","conceptCode":"C28746","definition":"A well-defined area of unequivocally increased signal intensity on MRI or CT scan images compared with the normal-appearing surrounding tissues, following intravenous injection of gadolinium-based contrast material.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Non-Target","conceptCode":"C25592","definition":"Other than the one for which something is done.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Response Assessment in Neuro-Oncology Criteria","conceptCode":"C114879","definition":"An update to the MacDonald criteria for assessing disease progression and treatment response in glioblastoma multiforme (GBM).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F7407222-2173-A99D-E040-BB89AD437A18","latestVersionIndicator":"Yes","beginDate":"2014-04-17","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-04-17","modifiedBy":"ONEDATA","dateModified":"2014-04-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F72BFCFB-F959-6C75-E040-BB89AD433F47","latestVersionIndicator":"Yes","beginDate":"2014-04-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-04-16","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4273313","version":"1","preferredName":"T1 Gadolinium Enhancing Lesion Follow-up Status","preferredDefinition":"A condition or state at a particular time.","longName":"RANOT1GADSTAT","context":"Alliance","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not applicable","valueDescription":"Not applicable","ValueMeaning":{"publicId":"2581003","version":"1","preferredName":"Not applicable","longName":"2581003v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0978-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":"2023.3.6 Added Alt VM-COG. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F72E9D8D-D7B3-E335-E040-BB89AD43012F","beginDate":"2014-04-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-04-16","modifiedBy":"ONEDATA","dateModified":"2014-04-16","deletedIndicator":"No"},{"value":"Not all evaluated","valueDescription":"Not all evaluated","ValueMeaning":{"publicId":"4273314","version":"1","preferredName":"Not all evaluated","longName":"4273314","preferredDefinition":"Not all evaluated","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F72E9D8D-D7BD-E335-E040-BB89AD43012F","latestVersionIndicator":"Yes","beginDate":"2014-04-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-04-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F72E9D8D-D7D6-E335-E040-BB89AD43012F","beginDate":"2014-04-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-04-16","modifiedBy":"ONEDATA","dateModified":"2014-04-16","deletedIndicator":"No"},{"value":"Confirmed PD","valueDescription":"Confirmation Disease Progression","ValueMeaning":{"publicId":"4273170","version":"1","preferredName":"Confirmation Disease Progression","longName":"4273170","preferredDefinition":"Having been established or verified.: The worsening of a disease over time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease Progression","conceptCode":"C17747","definition":"A process that manifests as the worsening of a disease over time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F72DFE87-DE7B-5FDE-E040-BB89AD433D0A","latestVersionIndicator":"Yes","beginDate":"2014-04-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-04-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F72E9D8D-D7E0-E335-E040-BB89AD43012F","beginDate":"2014-04-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-04-16","modifiedBy":"ONEDATA","dateModified":"2014-04-16","deletedIndicator":"No"},{"value":"Preliminary PD","valueDescription":"Not Confirmed Disease Progression","ValueMeaning":{"publicId":"4273171","version":"1","preferredName":"Not Confirmed Disease Progression","longName":"4273171","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Having been established or verified.: The worsening of a disease over time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease Progression","conceptCode":"C17747","definition":"A process that manifests as the worsening of a disease over time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F72DFE87-DEA2-5FDE-E040-BB89AD433D0A","latestVersionIndicator":"Yes","beginDate":"2014-04-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-04-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F72E9D8D-D7EA-E335-E040-BB89AD43012F","beginDate":"2014-04-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-04-16","modifiedBy":"ONEDATA","dateModified":"2014-04-16","deletedIndicator":"No"},{"value":"SD","valueDescription":"Stable Disease","ValueMeaning":{"publicId":"2560100","version":"1","preferredName":"Stable Disease","longName":"2560100","preferredDefinition":"Cancer that is neither decreasing nor increasing in extent or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stable Disease","conceptCode":"C18213","definition":"A disease that is neither decreasing nor increasing in extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B7D1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2022-09-13","changeDescription":"Manually curated for OHSU 10262","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F72E9D8D-D7F4-E335-E040-BB89AD43012F","beginDate":"2014-04-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-04-16","modifiedBy":"ONEDATA","dateModified":"2014-04-16","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2404650","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"005AD6E5-057F-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F72E9D8D-D79F-E335-E040-BB89AD43012F","latestVersionIndicator":"Yes","beginDate":"2014-04-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-04-16","modifiedBy":"CAMPBELB","dateModified":"2015-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"RANOT1GADSTAT","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"Follow-up status of T1 gadoli","type":"Preferred Question Text","description":"Follow-up status of T1 gadolinium enhancing (T1gad+) non-target lesion sites","url":null,"context":"Alliance"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F7407222-2197-A99D-E040-BB89AD437A18","latestVersionIndicator":"Yes","beginDate":"2014-04-17","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2014-04-17","modifiedBy":"FORMBUILDER","dateModified":"2014-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}